Introduction: The study objective was to evaluate sedative and physiologic effects of midazolam associated with a combination of methadone and alfaxalone for IM premedication in dogs. Methods: Sixteen healthy dogs of various breeds, weighing 5–12 kg, classified ASA status I-II, randomly received a combination of 0.5 mg kg−1 of methadone and 1 mg kg−1 of alfaxalone with (MMA) or without (MA) 0.5 mg kg−1 of midazolam by IM injection. Quality of sedation was assessed at 10, 15, 20 and 25 minutes post-injection, by an observer blinded to treatment. Cardiovascular, respiratory variables and additional intravenous alfaxalone required for endotracheal intubation were recorded. Data were analyzed with mixed-effect linear model on rank or Mann-Whitney rank-sum test (p≤0.05). Results: There was no significant difference over time in heart rate, respiratory rate, systolic blood pressure, SpO2 and temperature between MA and MMA premedication. Sedation increased over time (p < 0.01), however dogs premedicated with MMA appeared significantly less sedated than dogs premedicated with MA at 15 (p=0.02), 20 (p=0.02) and 25 minutes (p=0.01) post-injection. This was substantiated by the fact that dogs premedicated with MMA were almost four times more likely to show delirium than those premedicated with MA (OR 3.95, CI 0.69-7.21, p=0.02). The amount of alfaxalone needed for intubation did not differ between treatments (p=0.92). Conclusion: Results suggest that adding midazolam to an IM combination of methadone and alfaxalone does not improve sedation scores or amount of agent needed for intubation in healthy dogs.
Evaluation of a combination of alfaxalone and methadone, with or without midazolam, for premedication in healthy dogs / Micieli, F.; Duffee, L. R.; Chiavaccini, L.; Vesce, G.; Gianotti, G.. - In: VETERINARY ANAESTHESIA AND ANALGESIA. - ISSN 1467-2987. - 44:5(2017), pp. 1262.e9-1262.e9. [10.1016/j.vaa.2017.09.018]
Evaluation of a combination of alfaxalone and methadone, with or without midazolam, for premedication in healthy dogs
Micieli, F.
Investigation
;Vesce, G.Supervision
;
2017
Abstract
Introduction: The study objective was to evaluate sedative and physiologic effects of midazolam associated with a combination of methadone and alfaxalone for IM premedication in dogs. Methods: Sixteen healthy dogs of various breeds, weighing 5–12 kg, classified ASA status I-II, randomly received a combination of 0.5 mg kg−1 of methadone and 1 mg kg−1 of alfaxalone with (MMA) or without (MA) 0.5 mg kg−1 of midazolam by IM injection. Quality of sedation was assessed at 10, 15, 20 and 25 minutes post-injection, by an observer blinded to treatment. Cardiovascular, respiratory variables and additional intravenous alfaxalone required for endotracheal intubation were recorded. Data were analyzed with mixed-effect linear model on rank or Mann-Whitney rank-sum test (p≤0.05). Results: There was no significant difference over time in heart rate, respiratory rate, systolic blood pressure, SpO2 and temperature between MA and MMA premedication. Sedation increased over time (p < 0.01), however dogs premedicated with MMA appeared significantly less sedated than dogs premedicated with MA at 15 (p=0.02), 20 (p=0.02) and 25 minutes (p=0.01) post-injection. This was substantiated by the fact that dogs premedicated with MMA were almost four times more likely to show delirium than those premedicated with MA (OR 3.95, CI 0.69-7.21, p=0.02). The amount of alfaxalone needed for intubation did not differ between treatments (p=0.92). Conclusion: Results suggest that adding midazolam to an IM combination of methadone and alfaxalone does not improve sedation scores or amount of agent needed for intubation in healthy dogs.File | Dimensione | Formato | |
---|---|---|---|
Evaluation of a combination of alfaxalone and methadone, with or without midazolam, for premedication in healthy dogs PIIS1467298717302982.pdf
accesso aperto
Descrizione: abstract
Tipologia:
Abstract
Licenza:
Dominio pubblico
Dimensione
44.65 kB
Formato
Adobe PDF
|
44.65 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.